pembrolizumab,mRNA-4157
merck,moderna
['melanoma', 'merck', 'moderna']
promising news from #aacr23/#aacr2023: personalized #mrna cancer vaccine plus keytuda lowered risk of recurrence or death after surgery by 44% in people with advanced #melanoma. 
Medical journalist. Science editor for @POZmagazine, @Hep & @CancerHealth. Words for @aidsmap, @Slate, @eBARnews. Research beagle adopter.